Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of novel recurrent ETV6-IgH fusions in primary central nervous system lymphoma.
Bruno A, Labreche K, Daniau M, Boisselier B, Gauchotte G, Royer-Perron L, Rahimian A, Lemoine F, de la Grange P, Guégan J, Bielle F, Polivka M, Adam C, Meyronet D, Figarella-Branger D, Villa C, Chrétien F, Eimer S, Davi F, Rousseau A, Houillier C, Soussain C, Mokhtari K, Hoang-Xuan K, Alentorn A. Bruno A, et al. Among authors: royer perron l. Neuro Oncol. 2018 Jul 5;20(8):1092-1100. doi: 10.1093/neuonc/noy019. Neuro Oncol. 2018. PMID: 29432597 Free PMC article.
Management of primary central nervous system lymphoma.
Royer-Perron L, Hoang-Xuan K. Royer-Perron L, et al. Presse Med. 2018 Nov-Dec;47(11-12 Pt 2):e213-e244. doi: 10.1016/j.lpm.2018.04.016. Epub 2018 Nov 8. Presse Med. 2018. PMID: 30416008 Review.
[Primary central nervous system lymphoma].
Royer-Perron L, Hoang-Xuan K, Houillier C. Royer-Perron L, et al. Rev Prat. 2016 Apr;66(4):419-422. Rev Prat. 2016. PMID: 30512707 French.
A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network study.
Labreche K, Daniau M, Sud A, Law PJ, Royer-Perron L, Holroyd A, Broderick P, Went M, Benazra M, Ahle G, Soubeyran P, Taillandier L, Chinot OL, Casasnovas O, Bay JO, Jardin F, Oberic L, Fabbro M, Damaj G, Brion A, Mokhtari K, Philippe C, Sanson M, Houillier C, Soussain C, Hoang-Xuan K, Houlston RS, Alentorn A; LOC Network. Labreche K, et al. Among authors: royer perron l. Neuro Oncol. 2019 Aug 5;21(8):1039-1048. doi: 10.1093/neuonc/noz088. Neuro Oncol. 2019. PMID: 31102405 Free PMC article.
Primary CNS lymphoma patient-derived orthotopic xenograft model capture the biological and molecular characteristics of the disease.
Pouzoulet F, Alentorn A, Royer-Perron L, Assayag F, Mokhtari K, Labiod D, Le Garff-Tavernier M, Daniau M, Menet E, Peyre M, Schnitzler A, Guegan J, Davi F, Hoang-Xuan K, Soussain C. Pouzoulet F, et al. Among authors: royer perron l. Blood Cells Mol Dis. 2019 Mar;75:1-10. doi: 10.1016/j.bcmd.2018.11.005. Epub 2018 Nov 16. Blood Cells Mol Dis. 2019. PMID: 30502564
[Intracranial tumors].
Birzu C, Royer-Perron L, Hoang-Xuan K. Birzu C, et al. Among authors: royer perron l. Rev Prat. 2020 Feb;70(2):e39-e46. Rev Prat. 2020. PMID: 32877149 French. No abstract available.
Identification of growth hormone receptor as a relevant target for precision medicine in low-EGFR expressing glioblastoma.
Verreault M, Segoviano Vilchis I, Rosenberg S, Lemaire N, Schmitt C, Guehennec J, Royer-Perron L, Thomas JL, Lam TT, Dingli F, Loew D, Ducray F, Paris S, Carpentier C, Marie Y, Laigle-Donadey F, Rousseau A, Pigat N, Boutillon F, Bielle F, Mokhtari K, Frank SJ, de Reyniès A, Hoang-Xuan K, Sanson M, Goffin V, Idbaih A. Verreault M, et al. Among authors: royer perron l. Clin Transl Med. 2022 Jul;12(7):e939. doi: 10.1002/ctm2.939. Clin Transl Med. 2022. PMID: 35808822 Free PMC article.
11 results